Translational Development Acquisition Corp.
NASDAQ:TDACShell Companies
-$0.01 today
- Market cap
- $267.99M
- Beta
- 0.01
- P/E (TTM)
- 29.8
- EPS (TTM)
- $0.36
Volume 0.47M
Average 0.10M
TDAC Retained Earnings
Cumulative profits kept in the business rather than paid out as dividends.
Translational Development Acquisition Corp.NASDAQ: TDAC
Retained Earnings · Q1 FY2026 · quarter ended Mar 2026
Retained earnings remains negative
Q1 FY2026 retained earnings was -$6.82M, compared with -$5.95M a year earlier.
Context
- Retained earnings amounted to 3.7% of total assets at the end of Q1 FY2026, up 0.4 pp from a year earlier.
- Retained earnings grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether retained earnings keeps falling in the next quarterly balance sheet after a -14.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Retained Earnings history
USD · from the balance sheet
- Latest · FY2025
- (6.54M) USD
- Year-over-year change
- -16.9%
| Period | Period end | Retained Earnings | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (6.54M) | -16.9% |
| FY2024 | 2024-12-31 | (5.6M) | -951.0% |
| FY2023 | 2023-12-31 | (532.66K) | -1030.7% |
| FY2022 | 2022-12-31 | (47.11K) | — |
Retained Earnings vs competitors
How TDAC compares with its peers on the latest reported figures
- TDAC's Mar 2026 retained earnings of -$6.82M is the 3rd highest of the 7 companies compared; the peer median is -$8.38M.
- Its year-over-year change of -14.8% is the highest of 6, against a peer median of -35.9%.
- Retained earnings amounts to 3.7% of total assets for TDAC, versus a peer median of 4.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2025 | -$47.55K | — | — | 11.4% | |
NTWONewbury Street II Acquisition Corp | Mar 2026 | -$5.5M | -15.0% | — | 3.0% |
| Mar 2026 | -$6.82M | -14.8% | — | 3.7% | |
MACIMelar Acquisition Corp. I | Mar 2026 | -$7.72M | -35.9% | — | 4.4% |
| Mar 2026 | -$9.04M | -35.1% | — | 4.9% | |
| Mar 2026 | -$10.57M | -9557.1% | — | 4.4% | |
| Mar 2026 | -$22.81M | -713.1% | — | 10.9% | |
| Peer median (excluding TDAC) | -$8.38M | -35.9% | — | 4.6% | |
Competitors are the stored peer set for TDAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Translational Development Acquisition Corp.
NASDAQ:TDAC
Intrinsic Alpha fair value
Locked
Current Price
$10.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.